MissionIR Articles
-
India Globalization Capital, Inc. (NYSE: IGC) Announces Alzheimer’s Drug Candidate Targeting Aβ Proteins
More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the…
-
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Linking THC to Decrease in Aβ40 Protein Production
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at…
-
Moxian, Inc. (NASDAQ: MOXC) Shifts to Joint Venture Strategy in Effort to Penetrate Key Markets in China
Crystal Equity Research, encouraged by new joint venture strategy, forecasts rising revenue for Moxian (http://dtn.fm/Q8Fva) Key to market growth is UnionPay’s payment module in Moxian+ app MOXC now targets larger $2-4 million businesses for Moxian+…
-
MissionIRNewsBreaks – Monaker Group, Inc. (MKGI) Divests Non-Core Assets, Eliminates Convertible Debt ahead of Nasdaq Application
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has divested certain non-core assets for total consideration of $2.9 million. Additionally, the company has completed the conversion of $1.4 million…
-
Net Element (NASDAQ: NETE) and the Growing Value of the Payments Processing Business
Non-bank payment processing at $1.2 trillion, with 12.8% CAGR forecast through 2021 Large bank takeovers already underway NETE operating the right business in the right sector at the right time Savvy investors always look to…
-
MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) a Dark Horse in the Race to Treat Alzheimer’s
Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones.…
-
Moxian, Inc. (NASDAQ: MOXC) Ready for a 75% Upside Ride?
Crystal Equity Research maintains $5.25 price target for Moxian 75% upside from current price Price appreciation could be even higher depending on paid user conversions Crystal Equity Research published a research report on Moxian, Inc.…
-
India Globalization Capital, Inc. (NYSE: IGC) Growth Potential Fueled by Phytocannabinoid Treatments
Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of…
-
Net Element (NASDAQ: NETE) Maintains Listing following Meeting with Nasdaq Hearings Panel
Nasdaq Hearings Panel grants decision on listing based on shareholder equity and minimum bid issues, conditional on NETE providing evidence of compliance by October 20, 2017 NETE says impact of its cost cutting program should…
-
Exciting Potential for Growth Fuels Net Element (NASDAQ: NETE) as E-commerce and Consumers Converge
2017 second quarter net revenues up 18 percent to $16.1 million PayOnline, a flexible e-commerce payment solutions platform, launches in U.S. Net Element is strategically poised for growth in the U.S. and emerging countries Mobile-based…
-
India Globalization Capital, Inc. (NYSE: IGC) – The Pros are Already Picking Horses
Alzheimer’s is America’s most expensive disease, with a new diagnosis every 66 seconds IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise Low market cap could make IGC a…
-
MissionIRNewsBreaks – Crystal Equity Research Reaffirms Price Target of $5.25 for Moxian, Inc. (NASDAQ: MOXC)
In January 2017, Crystal Equity Research LLC published an initial report on Moxian, Inc. (NASDAQ: MOXC) with a price target of $5.25, and that price target remains unchanged as of an August 15 updated report…
-
MissionIRNewsBreaks – Net Element (NASDAQ: NETE) Faces Plentiful Growth Opportunities as US E-commerce Market Continues to Grow
The quickly growing e-commerce market in the United States provides plentiful opportunities for investment into online payment solution providers like Net Element, Inc. (NASDAQ: NETE) and its subsidiary PayOnline, a groundbreaking and flexible payment processing…
-
Moxian, Inc. (NASDAQ: MOXC) Price Target of $5.25 Reaffirmed by Crystal Equity Research
Moxian praised for new joint venture strategy to help penetrate key markets in China Crystal Equity Research projects Moxian’s sales reaching $2.3 million in FY2018 Moxian adding three to its board of directors, including Liu…
-
India Globalization Capital’s (NYSE: IGC) Cannabis-Based Alzheimer’s Disease Treatment Increases Upside Potential
Alzheimer’s is a leading cause of dementia in adults in the United States IGC’s cannabis-based drug may reverse the buildup of beta-amyloid plaque Hyalolex and other phytocannabinoid-based drugs are fueling potential for the company’s market…
-
Smith-Midland Corporation (SMID) Reports 11.4% Jump in Sales, 69.9% Boost in Net Income for Quarter Ended June 30, 2017
The precast concrete manufacturer, for the half ended the same date, recorded a 14.1% rise in revenues and a 377% spike in net income Safety barrier project in Northern Virginia has SMID working at full…
-
India Globalization Capital, Inc. (NYSE: IGC) Focuses on Building Phytocannabinoid-based Pharmaceutical Portfolio
Core operations transitioned to phytocannabinoid-based therapies Four trial candidates targeting chronic pain, Alzheimer’s and other conditions Unique approach combining existing therapies with cannabinoids India Globalization Capital, Inc. (NYSE MKT: IGC) is developing disruptive new pharmaceutical…
-
MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Quarter Ended June 30, 2017
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the quarter ended June 30, 2017. “During the quarter,…
-
MissionIRNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Bridges Gap Between China’s Tech-Savvy New Consumer Class and Brick-and-Mortar Businesses
Catering to China’s up-and-coming, tech-savvy consumer class, Moxian, Inc. (NASDAQ: MOXC) is building a crucial bridge between e-commerce and brick-and-mortar retail, providing small- and medium-sized businesses with state-of-the-art turnkey solutions to help them harness Web…
-
Monaker Group, Inc. (MKGI) Raises $3M to Strengthen Booking Engine as It Prepares for Uplisting to NASDAQ
Booking engine as a B2B product set to drive growth NASDAQ listing in sight Fresh capital injection of $3 million With the completion of its proprietary booking engine late last year, Monaker Group, Inc. (OTCQB:…
Search Articles
Latest Articles
- MissionIRNewsBreaks – FAVO Capital (OTC: FAVO) President Shaun Quin Joins Forbes Business Council
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Signs MOU With CITIC to Develop Digital Infrastructure in Saudi Arabia
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Is Pushing the Boundaries of Performance in Growing Market
- Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlighted in Italian Press for Juve Stabia Player Development, Market Value Surge